Nathan Lacher, Ph.D.

Primary office:


Dr. Nathan Lacher is an Associate Research Fellow in Pfizer BioTherapeutics Pharmaceutical Sciences group in Chesterfield, MO.  His background and training are in analytical chemistry.  After obtaining a B.S. degree (Chemistry) from Buena Vista University (Storm Lake, IA) in 1999, Nate received a Ph.D. (Pharmaceutical Chemistry) in 2004 from Kansas University (Lawrence, KS) under the direction of Dr. Susan Lunte.  In 2004, Nate joined Pfizer working at the La Jolla Laboratories (La Jolla, CA) on the development of small molecule pharmaceuticals for ophthalmology and oncology in Analytical R&D.  Since 2005, he has worked on the development of biotherapeutic candidates covering a wide range of indications at the St. Louis Laboratories in Chesterfield, MO.  Nate currently leads a group within Project Progression Line #1 of Analytical R&D supporting development of monoclonal antibodies, prophylactic vaccines, and gene therapies. 


The SEARCH Symposium was partially funded by donations made to KU Student Endowment Board’s crowd-funding campaign, LaunchKU. If you would like to support our graduate student organizations and the 2020 SEARCH Symposium, please consider making a donation. Even the smallest donations make a difference. 


Thank you for supporting graduate students' efforts to promote science education and outreach, professional development events, and travel to professional meetings.

Twitter Feed
One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today